The Freud-1/CC2D1A family: Transcriptional regulators implicated in mental retardation

Journal of Neuroscience Research

Volumn 85, Issue 13, 2007, Pages 2833-2838

  Rogaeva, Anastasia ^a   Galaraga, Kimberly ^a   Albert, Paul R ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Cognition; Mental retardation; Repression; Serotonin; Transcription

Indexed keywords

PROTEIN FREUD 1; REPRESSOR PROTEIN; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

AUTISM; CC2D1A GENE; COGNITION; COGNITIVE DEFECT; DNA BINDING; GENE; GENE DELETION; GENE MUTATION; GENE TARGETING; HUMAN; MENTAL DEFICIENCY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SHORT SURVEY;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELIX-LOOP-HELIX MOTIFS; HUMANS; MENTAL RETARDATION;

EID: 34948818674     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21277     Document Type: Short Survey

References (46)

1. Albert PR, Lemonde S. 2004. 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 10:575-593.
2. Barnes NM, Sharp T. 1999. A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
3. Basel-Vanagaite L, Alkelai A, Straussberg R, Magal N, Inbar D, Mahajna M, Shohat M. 2003. Mapping of a new locus for autosomal recessive nonsyndromic mental retardation in the chromosomal region 19p13.12-p13.2: further genetic heterogeneity. J Med Genet 40:729-732.
4. Basel-Vanagaite L, Attia R, Yahav M, Ferland RJ, Anteki L, Walsh CA, Olender T, Straussberg R, Magal N, Taub E, Drasinover V, Alkelai A, Bercovich D, Rechavi G, Simon AJ, Shohat M. 2006. The CC2D1A, a member of a new gene family with C2 domains, is involved in autosomal recessive non-syndromic mental retardation. J Med Genet 43:203-210.
5. Basel-Vanagaite L, Taub E, Halpern GJ, Drasinover V, Magal N, Davidov B, Zlotogora J, Shohat M. 2007. Genetic screening for autosomal recessive nonsyndromic mental retardation in an isolated population in Israel. Eur J Hum Genet 15:250-253.
6. Berton O, Nestler EJ. 2006. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137-151.
7. Branchi I, Bichler Z, Berger-Sweeney J, Ricceri L. 2003. Animal models of mental retardation: from gene to cognitive function. Neurosci Biobehav Rev 27:141-153.
8. Burkhard P, Stetefeld J, Strelkov SV. 2001. Coiled coils: a highly versatile protein folding motif. Trends Cell Biol 11:82-88.
9. Chechlacz M, Gleeson JG. 2003. Is mental retardation a defect of synapse structure and function? Pediatr Neurol 29:11-17.
10. D'Adamo P, Welzl H, Papadimitriou S, Raffaele di Barletta M, Tiveron C, Tatangelo L, Pozzi L, Chapman PF, Knevett SG, Ramsay MF, Valtorta F, Leoni C, Menegon A, Wolfer DP, Lipp HP, Toniolo D. 2002. Deletion of the mental retardation gene Gdi1 impairs associative memory and alters social behavior in mice. Hum Mol Genet 11:2567-2580.
11. Garcia J, Gerber SH, Sugita S, Sudhof TC, Rizo J. 2004. A conformational switch in the piccolo C2A domain regulated by alternative splicing. Nat Struct Mol Biol 11:45-53.
12. Graybiel AM. 2005. The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol 15:638-644.
13. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R. 2002. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416:396-400.
14. Hadjighasem M, Lemonde S, Albert PR. 2005. Freud-2: a novel repressor of the 5-HT1A receptor gene. Canadian College of Neuropsychopharmacology Annual Meeting. St. John, Newfoundland, Canada: Canadian College of Neuropsychopharmacology.
15. Harder JA, Ridley RM. 2000. The 5-HT1A antagonist, WAY 100 635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys. Neuropharmacology 39:547-552.
16. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, Tecott LH. 1998. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A 95:15049-15054.
17. Higgins JJ, Pucilowska J, Lombardi RQ, Rooney JP. 2004. A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology 63:1927-1931.
18. Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, Moore H, Kandel ER. 2006. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49:603-615.
19. Kusserow H, Davies B, Hortnagl H, Voigt I, Stroh T, Bert B, Deng DR, Fink H, Veh RW, Theuring F. 2004. Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors. Brain Res Mol Brain Res 129:104-116.
20. Lanfumey L, Hamon M. 2004. 5-HT1 receptors. Curr Drug Target CNS Neurol Disord 3:1-10.
21. Lemonde S, Rogaeva A, Albert PR. 2004. Cell type-dependent recruitment of trichostatin A-sensitive repression of the human 5-HT1A receptor gene. J Neurochem 88:857-868.
22. Leonardo ED, Hen R. 2006. Genetics of affective and anxiety disorders. Annu Rev Psychol 57:117-137.
23. Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, Nagano Y, Doi T, Shimotohno K, Harada T, Nishida E, Hayashi H, Sugano S. 2003. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22:3307-3318.
24. McCreary AC, Glennon JC, Ashby CR, Meltzer HY, Li Z, Reinders JH, Hesselink MB, Long SK, Herremans AH, van Stuivenberg H, Feenstra RW, Kruse CG. 2007. SLV313 (1-(2,3-dihydro-benzo[1,4]-dioxin-5-yl)-4-[5-(4-fluoro-phenyl)- pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist potential antipsychotic drug. Neuropsychopharmacology (in press).
25. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D. 2003. NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 6:1072-1078.
26. Molinari F, Rio M, Meskenaite V, Encha-Razavi F, Auge J, Bacq D, Briault S, Vekemans M, Munnich A, Attie-Bitach T, Sonderegger P, Colleaux L. 2002. Truncating neurotrypsin mutation in autosomal recessive nonsyndromic mental retardation. Science 298:1779-1781.
27. Newman-Tancredi A, Assie MB, Leduc N, Ormiere AM, Danty N, Cosi C. 2005. Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia. Int J Neuropsychopharmacol 8:341-356.
28. Ou XM, Jafar-Nejad H, Storring JM, Meng JH, Lemonde S, Albert PR. 2000. Novel dual repressor elements for neuronal cell-specific transcription of the rat 5-HT1A receptor gene. J Biol Chem 275:8161-8168.
29. Ou XM, Lemonde S, Jafar-Nejad H, Bown CD, Goto A, Rogaeva A, Albert PR. 2003. Freud-1: a neuronal calcium-regulated repressor of the 5-HT1A receptor gene. J Neurosci 23:7415-7425.
30. Parks CL, Shenk T. 1996. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J Biol Chem 271:4417-4430.
31. Raymond FL. 2006. X linked mental retardation: a clinical guide. J Med Genet 43:193-200.
32. Raymond FL, Tarpey P. 2006. The genetics of mental retardation. Hum Mol Genet 15:R110-R116.
33. Rogaeva A, Albert PR. 2006. Promoter recognition and repression of serotonin-1A and dopamine-D2 gene by Freud-1/CC2D1A, a novel gene linked to mental retardation. International Society for Developmental Neuroscience. Banff, Alberta, Canada: Elsevier.
34. Rogaeva A, Galaraga K, Albert PR. 2005. Mechanism of calcium-sensitive regulation of serotonin-1A receptor gene expression by a novel repressor, human Freud-1 (long form). Washington, DC: Society for Neuroscience.
35. Ropers HH. 2006. X-linked mental retardation: many genes for a complex disorder. Curr Opin Genet Dev 16:260-269.
36. Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M. 2000. Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci U S A 97:14731-14736.
37. Schechter LE, Dawson LA, Harder JA. 2002. The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s disease. Curr Pharm Des 8:139-145.
38. Schechter LE, Smith DL, Rosenzweig-Lipson S, Sukoff SJ, Dawson LA, Marquis K, Jones D, Piesla M, Andree T, Nawoschik S, Harder JA, Womack MD, Buccafusco J, Terry AV, Hoebel B, Rada P, Kelly M, Abou-Gharbia M, Barrett JE, Childers W. 2005. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. J Pharmacol Exp Ther 314:1274-1289.
39. Storring JM, Charest A, Cheng P, Albert PR. 1999. TATA-driven transcriptional initiation and regulation of the rat serotonin 5-HT1A receptor gene. J Neurochem 72:2238-2247.
40. Sumiyoshi T, Meltzer HY. 2004. Serotonin 1A receptors in memory function. Am J Psychiatry 161:1505; author reply 1505-1506.
41. Sumiyoshi T, Matsui M, Nohara S, Yamashita I, Kurachi M, Sumiyoshi C, Jayathilake K, Meltzer HY. 2001a. Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am J Psychiatry 158:1722-1725.
42. Sumiyoshi T, Matsui M, Yamashita I, Nohara S, Kurachi M, Uehara T, Sumiyoshi S, Sumiyoshi C, Meltzer HY. 2001b. The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia. Biol Psychiatry 49:861-868.
43. Verot L, Alloisio N, Morle L, Bozon M, Touraine R, Plauchu H, Edery P. 2003. Localization of a non-syndromic X-linked mental retardation gene (MRX80) to Xq22-q24. Am J Med Genet A122:37-41.
44. Williamson MP. 1994. The structure and function of proline-rich regions in proteins. Biochem J 297:249-260.
45. Wolff M, Costet P, Gross C, Hen R, Segu L, Buhot MC. 2004. Age-dependent effects of serotonin-1A receptor gene deletion in spatial learning abilities in mice. Brain Res Mol Brain Res 130:39-48.
46. Zhou QY, Quaife CJ, Palmiter RD. 1995. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374:640-643.